These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 453129)

  • 21. [Recent advances in pathogenesis and diagnosis of constitutional hepatic dysfunction (Gilbert's syndrome) (author's transl)].
    Röllinghoff W; Preisig R
    Ther Umsch; 1978 Sep; 35(9):742-6. PubMed ID: 705684
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative dye loading tests using indocyanine green and bromsulphalein in Gilbert's constitutional idiopathic hyperbilirubinemia].
    Brügmann E; Sievers P
    Dtsch Z Verdau Stoffwechselkr; 1971; 31(4):191-3. PubMed ID: 5150342
    [No Abstract]   [Full Text] [Related]  

  • 23. Gilbert's syndrome and drug metabolism.
    Macklon AF; Savage RL; Rawlins MD
    Clin Pharmacokinet; 1979; 4(3):223-32. PubMed ID: 383356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of bilirubin and indocyanine green with the binding and conjugation of sulfobromophthalein by rat liver cytosol proteins.
    Davis DR; Yeary RA
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):373-88. PubMed ID: 7367753
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromsulfophthalein clearance and aminopyrine test in patients with Gilbert's syndrome.
    Bar-Meir S; Bar-Tal L; Papa MZ; Peled Y
    Isr J Med Sci; 1986 May; 22(5):376-9. PubMed ID: 3744786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Congenital non-hemolytic and non-conjugating-type hyperbilirubinemia].
    Kawasaki H; Sakai K; Irisa T; Amagase H; Hirayama C
    Naika; 1971 May; 27(5):957-64. PubMed ID: 5572497
    [No Abstract]   [Full Text] [Related]  

  • 27. [Positive diagnosis of Gilbert syndrome. Retrospective analysis of 59 cases with special reference to the nicotinic acid test].
    Preisig D; Bircher J; Preisig R
    Schweiz Med Wochenschr; 1982 Aug; 112(33):1122-9. PubMed ID: 7134940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid effects on hepatic disposition of dyes in mice.
    Hurwitz A; Fischer HR; Innis JD; Ronsse S; Ben-Zvi Z
    J Pharmacol Exp Ther; 1985 Mar; 232(3):617-23. PubMed ID: 3973820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Rotor's syndrome. Apropos of a case].
    Carre D; Civadier C; Foll Y; Talarmin B; Abgrall J
    Ann Gastroenterol Hepatol (Paris); 1994; 30(6):255-9. PubMed ID: 7847786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies of the interference between bilirubin metabolism and BSP metabolism in humans. Preliminary results].
    Gentilini P; Surrenti C; Candidi Tommasi A; Camilloni R
    Riv Crit Clin Med; 1968; 68():Suppl 6:850-8. PubMed ID: 5747759
    [No Abstract]   [Full Text] [Related]  

  • 31. New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias.
    Berthelot P; Dhumeaux D
    Gut; 1978 Jun; 19(6):474-80. PubMed ID: 98393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rotor's syndrome: a study on variations in pigment metabolism with age.
    Okumura H; Fukuda N; Aramaki T; Katsuta Y; Satomura K; Sato T; Yano T
    Gastroenterol Jpn; 1982; 17(1):15-20. PubMed ID: 7075930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new rat mutant with chronic conjugated hyperbilirubinemia and renal glomerular lesions.
    Hosokawa S; Tagaya O; Mikami T; Nozaki Y; Kawaguchi A; Yamatsu K; Shamoto M
    Lab Anim Sci; 1992 Feb; 42(1):27-34. PubMed ID: 1316504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of paclitaxel in a patient with ovarian cancer and hyperbilirubinemia due to Rotor's syndrome.
    Argon A; Aydiner A; Tas F; Saip P; Topuz E
    Gynecol Oncol; 2002 May; 85(2):362-4. PubMed ID: 11972401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mechanisms for increased clearance of dyes (BSP, ICG) by the liver].
    Poupon R; Barbare JC
    Gastroenterol Clin Biol; 1983 Feb; 7(2):222-3. PubMed ID: 6840470
    [No Abstract]   [Full Text] [Related]  

  • 36. Biliary excretion of conjugated sulfobromophthalein (BSP) in constitutional conjugated hyperbilirubinemias.
    Abe H; Okuda K
    Digestion; 1975; 13(5):272-83. PubMed ID: 1205014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Liver dye metabolism and constitutional indocyanine green retention syndrome in Japan (author's transl)].
    Shibata H; Toyama K
    Leber Magen Darm; 1976 Dec; 6(6):330-4. PubMed ID: 1018575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic storage and excretion of bilirubin in man.
    Raymond GD; Galambos JT
    Am J Gastroenterol; 1971 Feb; 55(2):135-44. PubMed ID: 5580257
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic hyperbilirubinemia associated with hepatic uptake and storage impairment. A new syndrome resembling that of the mutant Southdown sheep.
    Dhumeaux D; Berthelot P
    Gastroenterology; 1975 Oct; 69(4):988-93. PubMed ID: 1175891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Different elimination velocity of indocyanine green in liver diseases of various severity].
    Brügmann E
    Z Gesamte Inn Med; 1973 Sep; 28(17):523-6. PubMed ID: 4767186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.